Target Price | €15.69 |
Price | €11.92 |
Potential |
31.68%
register free of charge
|
Number of Estimates | 15 |
15 Analysts have issued a price target Teamviewer 2026 .
The average Teamviewer target price is €15.69.
This is
31.68%
register free of charge
€20.00
67.86%
register free of charge
€12.00
0.71%
register free of charge
|
|
A rating was issued by 16 analysts: 7 Analysts recommend Teamviewer to buy, 8 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Teamviewer stock has an average upside potential 2026 of
31.68%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million € | 671.42 | 768.60 |
7.14% | 14.47% | |
EBITDA Margin | 38.84% | 42.37% |
12.22% | 9.09% |
14 Analysts have issued a sales forecast Teamviewer 2025 . The average Teamviewer sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Teamviewer EBITDA forecast 2025. The average Teamviewer EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | 0.77 | 0.91 |
16.67% | 18.18% | |
P/E | 13.42 | |
EV/Sales | 2.97 |
10 Analysts have issued a Teamviewer forecast for earnings per share. The average Teamviewer <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Teamviewer stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
METZLER EQUITIES | Locked ➜ Locked | Locked | Jan 03 2025 |
BNP PARIBAS EXANE | Locked ➜ Locked | Locked | Jan 02 2025 |
WARBURG RESEARCH GMBH | Locked ➜ Locked | Locked | Dec 12 2024 |
BERENBERG | Locked ➜ Locked | Locked | Dec 12 2024 |
DZ BANK | Locked ➜ Locked | Locked | Dec 11 2024 |
MWB RESEARCH AG | Locked ➜ Locked | Locked | Dec 11 2024 |
EQUI.TS | Locked ➜ Locked | Locked | Dec 10 2024 |
Analyst Rating | Date |
---|---|
Locked
METZLER EQUITIES: Locked ➜ Locked
|
Jan 03 2025 |
Locked
BNP PARIBAS EXANE: Locked ➜ Locked
|
Jan 02 2025 |
Locked
WARBURG RESEARCH GMBH: Locked ➜ Locked
|
Dec 12 2024 |
Locked
BERENBERG: Locked ➜ Locked
|
Dec 12 2024 |
Locked
DZ BANK: Locked ➜ Locked
|
Dec 11 2024 |
Locked
MWB RESEARCH AG: Locked ➜ Locked
|
Dec 11 2024 |
Locked
EQUI.TS: Locked ➜ Locked
|
Dec 10 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.